Market Overview:
The global pegaspargase market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing demand for oncology drugs, and growing awareness about cancer treatments. The global pegaspargase market is segmented by type (5ml, 10ml), by application (hospital, pharmacy), and by region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). The 5ml type segment is expected to account for the largest share of the global pegaspargase market in 2018. This can be attributed to its lower price point as compared to 10ml type products. By application, hospital accounted for the majority share of the global pegaspargase market in 2017. This can be attributed to increasing number of hospitals worldwide and rising demand for oncology drugs.
Product Definition:
Pegaspargase is an enzyme that helps the body to break down proteins. It is used to treat cancer and other diseases.
5ml:
Pegaspargase is an enzyme that catalyzes the conversion of ?-glucosidic acid to glucosamine and pyrrolizine. It is used in treating osteoarthritis, rheumatoid arthritis, and gout by inhibiting cartilage degradation. Osteoarthritis (OA) affects around one out of every three individuals at some point in their lives.
10ml:
Pegaspargase is an enzyme that catalyzes the conversion of ADP to GDP in the cell. The product has a wide range of applications such as it can be used for treating cancer, cardiovascular diseases, and other disorders by increasing cellular energy production. Pegaspargase market size was valued at USD 88 million in 2016 and is expected to grow at a CAGR of XX% during the forecast period.
Application Insights:
The Pegaspargase Injection 5% (5ml) is used for the treatment of patients with atrial fibrillation, who are undergoing cardiac surgery. The product is also used in the management of patients suffering from chronic kidney disease and those receiving dialysis therapy.
In addition, Pegaspargase Injection 10% (10ml) is indicated for use in the treatment of AFib post open heart surgery and during percutaneous coronary intervention procedures. Furthermore, it can be used as an alternative to amiodarone in case a pacemaker implantation procedure cannot be performed due to patient resistance towards anticoagulants or intolerance towards them.
Pegaspargase injection 5%, when compared to other drugs available for atrial fibrillation; has fewer adverse effects such as allergic reactions.
Regional Analysis:
North America Pegaspargase Market Size was USD X Million in 2017 and is expected to grow at a CAGR of XX% over the forecast period. The growth can be attributed to the presence of key players, such as Pfizer Inc., in this region which has led to an increase in availability of medicines, such as pegaspargase, for treatment options for patients suffering from MPS III & IV disease states.
The market is expected witness significant growth due to rise in geriatric population base.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for pegaspargase and other oncology drugs in the coming years.
- Growing awareness about cancer treatments: There is a growing awareness among people about various types of cancers and their treatments. This is likely to boost the demand for pegaspargase and other oncology drugs in the near future.
- Rising healthcare expenditure: The global healthcare expenditure is rising rapidly, owing to increasing income levels and technological advancements in the field of medicine. This will create lucrative opportunities for players operating in the pegaspargase market over the forecast period.
- . Technological advancements: The pharmaceutical industry is witnessing rapid advancements in terms of technology, which are helping manufacturers develop better-quality products at lower costs.. This trend will benefit players operating in thpegaspargase market overthe forecast period .5) Increasing focus on R&D activities: Pharmaceutical companies are investing heavily inthe researchand development (R&D)of newdrugs,including those for treatingcancer patients,.Thiswill help themgain a stronger footholdin themarketand offer noveltreatment options to consumersin needof such therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Pegaspargase Market Research Report
By Type
5ml, 10ml
By Application
Hospital, Pharmacy
By Companies
Shire
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Pegaspargase Market Report Segments:
The global Pegaspargase market is segmented on the basis of:
Types
5ml, 10ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shire
Highlights of The Pegaspargase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5ml
- 10ml
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pegaspargase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pegaspargase is a drug used to treat cancer. It works by stopping the growth of cancer cells.
Some of the major companies in the pegaspargase market are Shire.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pegaspargase Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pegaspargase Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pegaspargase Market - Supply Chain
4.5. Global Pegaspargase Market Forecast
4.5.1. Pegaspargase Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pegaspargase Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pegaspargase Market Absolute $ Opportunity
5. Global Pegaspargase Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pegaspargase Market Size and Volume Forecast by Type
5.3.1. 5ml
5.3.2. 10ml
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pegaspargase Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pegaspargase Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Pharmacy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pegaspargase Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pegaspargase Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pegaspargase Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pegaspargase Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pegaspargase Demand Share Forecast, 2019-2026
9. North America Pegaspargase Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pegaspargase Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pegaspargase Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Pharmacy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pegaspargase Market Size and Volume Forecast by Type
9.7.1. 5ml
9.7.2. 10ml
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pegaspargase Demand Share Forecast, 2019-2026
10. Latin America Pegaspargase Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pegaspargase Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pegaspargase Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Pharmacy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pegaspargase Market Size and Volume Forecast by Type
10.7.1. 5ml
10.7.2. 10ml
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pegaspargase Demand Share Forecast, 2019-2026
11. Europe Pegaspargase Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pegaspargase Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pegaspargase Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Pharmacy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pegaspargase Market Size and Volume Forecast by Type
11.7.1. 5ml
11.7.2. 10ml
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Produc Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pegaspargase Demand Share, 2019-2026
12. Asia Pacific Pegaspargase Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pegaspargase Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pegaspargase Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Pharmacy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pegaspargase Market Size and Volume Forecast by Type
12.7.1. 5ml
12.7.2. 10ml
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pegaspargase Demand Share, 2019-2026
13. Middle East & Africa Pegaspargase Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pegaspargase Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pegaspargase Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Pharmacy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pegaspargase Market Size and Volume Forecast by Type
13.7.1. 5ml
13.7.2. 10ml
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pegaspargase Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pegaspargase Market: Market Share Analysis
14.2. Pegaspargase Distributors and Customers
14.3. Pegaspargase Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shire
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. COMPANY2
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook